Immediate Impact
1 by Nobel laureates 2 from Science/Nature 61 standout
Citing Papers
Digestive cancers: mechanisms, therapeutics and management
2025 Standout
Thirty years from FDA approval of pegylated liposomal doxorubicin (Doxil/Caelyx): an updated analysis and future perspective
2025 Standout
Works of Massimo Montano being referenced
Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild‐type KRAS advanced biliary tract cancer: A randomized phase 2 trial (V ecti‐BIL study)
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Massimo Montano | 142 | 124 | 21 | 53 | 9 | 179 | |
| Kilian Salerno May | 131 | 50 | 13 | 87 | 12 | 227 | |
| K.R. Durrant | 129 | 85 | 14 | 102 | 13 | 277 | |
| Beverly Schmocker | 79 | 66 | 32 | 132 | 6 | 252 | |
| Mélodie Tazdait | 219 | 45 | 24 | 129 | 7 | 262 | |
| Marieke S. Walma | 244 | 120 | 4 | 95 | 13 | 290 | |
| Mohammad Al Efishat | 164 | 131 | 3 | 61 | 12 | 215 | |
| Amita Mistry | 212 | 43 | 10 | 108 | 8 | 242 | |
| S Denley | 179 | 86 | 11 | 44 | 6 | 226 | |
| N I Markham | 93 | 105 | 54 | 47 | 10 | 280 | |
| Pascale Bernard | 108 | 88 | 9 | 78 | 8 | 272 |
All Works
Loading papers...